Skip to content

Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19)

A prospective randomized controlled trial comparing the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth with moderate to severe Coronavirus disease (COVID-19) compared to standard treatment

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200607047675N1
Enrollment
122
Registered
2020-06-15
Start date
2020-06-19
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19

Interventions

Intervention 1: Intervention group: 300mg of soft Ferula gum and 150mg of soft tragacanth gum: twice a day, and the national guidelines for the treatment of COVID-19. Intervention 2: Control group: t

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: PCR confirmed diagnostic chest CT scan Consent for voluntary participation Hospitalization

Exclusion criteria

Exclusion criteria: Patients with end stage heart failure Recent cardiac intervention (less than 2 months): coronary angioplasty, ICD, CABG, Valvuloplasty or replacement Pulmonary fibrosis or advanced COPD End stage kidney or liver disease Pregnant or lactating ladies Patients on immunosuppressive therapy Active tuberculosis Active hepatitis The critical stage of COID19

Design outcomes

Primary

MeasureTime frame
Oxygen saturation (=94% on room air). Timepoint: Day 1 and 14. Method of measurement: pulse oximetry.;Lymphocyte count. Timepoint: Day 1 and 14. Method of measurement: Complete Blood Count.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNayereh Esmaeilzadeh

Mashhad University of Medical Sciences

esmaeilzadehn1@mums.ac.ir+98 51 3841 5222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026